mitomycin has been researched along with Pulmonary Hypertension in 10 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After treatment with mitomycin C, a patient developed pulmonary hypertension with interstitial infiltrates, microangiopathic hemolytic anemia, systemic hypertension, and renal failure with the nephrotic syndrome." | 7.67 | Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome. ( McCarthy, JT; Staats, BA, 1986) |
| "Mitomycin was incriminated in both cases." | 5.31 | Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. ( Capron, F; Gagnadoux, F; Lebeau, B, 2002) |
| "A 68-year-old man was treated with FAM (5-fluorouracil, doxorubicin [Adriamycin], mitomycin-C) for metastic gastric adenocarcinoma." | 3.67 | Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma. ( Kerwin, DM; Smith, FP; Tsou, E; Waldhorn, RE, 1984) |
| "After treatment with mitomycin C, a patient developed pulmonary hypertension with interstitial infiltrates, microangiopathic hemolytic anemia, systemic hypertension, and renal failure with the nephrotic syndrome." | 3.67 | Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome. ( McCarthy, JT; Staats, BA, 1986) |
| "Mitomycin was incriminated in both cases." | 1.31 | Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. ( Capron, F; Gagnadoux, F; Lebeau, B, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Certain, MC | 1 |
| Chaumais, MC | 4 |
| Jaïs, X | 2 |
| Savale, L | 3 |
| Seferian, A | 2 |
| Parent, F | 1 |
| Georges, M | 1 |
| Favrolt, N | 1 |
| Bourdin, A | 1 |
| Boissin, C | 1 |
| Cottin, V | 1 |
| Traclet, J | 1 |
| Renard, S | 1 |
| Noel, V | 1 |
| Picard, F | 1 |
| Girerd, B | 1 |
| Ghigna, MR | 1 |
| Perros, F | 2 |
| Sitbon, O | 2 |
| Bonniaud, P | 1 |
| Humbert, M | 4 |
| Montani, D | 4 |
| Zhang, C | 1 |
| Lu, W | 1 |
| Luo, X | 1 |
| Liu, S | 1 |
| Li, Y | 1 |
| Zheng, Q | 1 |
| Liu, W | 1 |
| Wu, X | 1 |
| Chen, Y | 1 |
| Jiang, Q | 1 |
| Zhang, Z | 1 |
| Gu, G | 1 |
| Chen, J | 1 |
| Chen, H | 1 |
| Liao, J | 1 |
| Liu, C | 1 |
| Hong, C | 1 |
| Tang, H | 1 |
| Sun, D | 1 |
| Yang, K | 1 |
| Wang, J | 1 |
| Dorfmuller, P | 1 |
| O'Connell, C | 1 |
| Guignabert, C | 1 |
| Botros, L | 1 |
| Van Nieuw Amerongen, GP | 1 |
| Vonk Noordegraaf, A | 1 |
| Bogaard, HJ | 1 |
| Waldhorn, RE | 1 |
| Tsou, E | 1 |
| Smith, FP | 1 |
| Kerwin, DM | 1 |
| Gagnadoux, F | 1 |
| Capron, F | 1 |
| Lebeau, B | 1 |
| Mackintosh, J | 1 |
| McCarthy, JT | 1 |
| Staats, BA | 1 |
10 other studies available for mitomycin and Pulmonary Hypertension
| Article | Year |
|---|---|
Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.
Topics: Antibiotics, Antineoplastic; Cardiac Catheterization; Female; France; Functional Status; Humans; Hyp | 2021 |
Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats.
Topics: Animals; Endothelial Cells; Endothelium; Humans; Hypertension, Pulmonary; Mitomycin; Pulmonary Veno- | 2021 |
Lung transplantation for mitomycin-induced pulmonary veno-occlusive disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Female; Fluorouracil; Humans; Hypert | 2017 |
Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension.
Topics: Adverse Drug Reaction Reporting Systems; Antibiotics, Antineoplastic; Attitude of Health Personnel; | 2018 |
Recovery from mitomycin-induced pulmonary arterial hypertension.
Topics: Antineoplastic Agents; Anus Neoplasms; Bosentan; Carcinoma; Endothelin Receptor Antagonists; Female; | 2014 |
[Mitomycin-induced pulmonary veno-occlusive disease: A rare but severe complication].
Topics: Amifostine; Animals; Antibiotics, Antineoplastic; Anus Neoplasms; Humans; Hypertension, Pulmonary; M | 2017 |
Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
Topics: Adenocarcinoma; Aged; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin | 1984 |
Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma.
Topics: Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Echocardiogr | 2002 |
Cardiopulmonary complications of mitomycin-C.
Topics: Anemia, Hemolytic; Female; Heart Failure; Humans; Hypertension, Pulmonary; Middle Aged; Mitomycin; M | 1990 |
Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
Topics: Adenocarcinoma; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Colonic N | 1986 |